Hasan Hasan1, Maggie Burrows2,3, Dilan S Athauda2,4, Bruce Hellman5, Ben James5, Thomas Warner2,3, Thomas Foltynie2,4, Gavin Giovannoni6,7, Andrew J Lees2,3, Alastair J Noyce2,3,6. 1. Institute of Neurology Queen Square University College London, London UK. 2. Department of Clinical and Movement Neurosciences Institute of Neurology Queen Square, University College London, London UK. 3. Reta Lila Weston Institute of Neurological Studies Institute of Neurology, University College London London UK. 4. National Hospital for Neurology and Neurosurgery London UK. 5. uMotif Ltd London UK. 6. Blizard Institute Queen Mary University London, Barts and the London School of Medicine and Dentistry London UK. 7. Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry Queen Mary University of London London UK.
Abstract
BACKGROUND: The BRadykinesia Akinesia INcoordination (BRAIN) tap test is an online keyboard tapping task that has been previously validated to assess upper limb motor function in Parkinson's disease (PD). OBJECTIVES: To develop a new parameter that detects a sequence effect and to reliably distinguish between PD patients on and off medication. In addition, we sought to validate a mobile version of the test for use on smartphones and tablet devices. METHODS: The BRAIN test scores in 61 patients with PD and 93 healthy controls were compared. A range of established parameters captured number and accuracy of alternate taps. The new velocity score recorded the intertap speed. Decrement in the velocity score was used as a marker for the sequence effect. In the validation phase, 19 PD patients and 19 controls were tested using different hardware including mobile devices. RESULTS: Quantified slopes from the velocity score demonstrated bradykinesia (sequence effect) in PD patients (slope cut-off -0.002) with 58% sensitivity and 81% specificity (discovery phase of the study) and 65% sensitivity and 88% specificity (validation phase). All BRAIN test parameters differentiated between on and off medication states in PD. Differentiation between PD patients and controls was possible on all hardware versions of the test. CONCLUSION: The BRAIN tap test is a simple, user-friendly, and free-to-use tool for the assessment of upper limb motor dysfunction in PD, which now includes a measure of bradykinesia.
BACKGROUND: The BRadykinesia Akinesia INcoordination (BRAIN) tap test is an online keyboard tapping task that has been previously validated to assess upper limb motor function in Parkinson's disease (PD). OBJECTIVES: To develop a new parameter that detects a sequence effect and to reliably distinguish between PD patients on and off medication. In addition, we sought to validate a mobile version of the test for use on smartphones and tablet devices. METHODS: The BRAIN test scores in 61 patients with PD and 93 healthy controls were compared. A range of established parameters captured number and accuracy of alternate taps. The new velocity score recorded the intertap speed. Decrement in the velocity score was used as a marker for the sequence effect. In the validation phase, 19 PD patients and 19 controls were tested using different hardware including mobile devices. RESULTS: Quantified slopes from the velocity score demonstrated bradykinesia (sequence effect) in PD patients (slope cut-off -0.002) with 58% sensitivity and 81% specificity (discovery phase of the study) and 65% sensitivity and 88% specificity (validation phase). All BRAIN test parameters differentiated between on and off medication states in PD. Differentiation between PD patients and controls was possible on all hardware versions of the test. CONCLUSION: The BRAIN tap test is a simple, user-friendly, and free-to-use tool for the assessment of upper limb motor dysfunction in PD, which now includes a measure of bradykinesia.
Entities:
Keywords:
Parkinson's disease; ambulatory monitoring; digital health; hypokinesia; objective measures
Authors: Ana Lisa Taylor Tavares; Gregory S X E Jefferis; Mandy Koop; Bruce C Hill; Trevor Hastie; Gary Heit; Helen M Bronte-Stewart Journal: Mov Disord Date: 2005-10 Impact factor: 10.338
Authors: Thomas O Mera; Danielle E Filipkowski; David E Riley; Christina M Whitney; Benjamin L Walter; Steven A Gunzler; Joseph P Giuffrida Journal: Gait Posture Date: 2012-12-05 Impact factor: 2.840
Authors: Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle Journal: Mov Disord Date: 2008-11-15 Impact factor: 10.338
Authors: Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Charles H Knowles; John Hardy; Gavin Giovannoni; Saiji Nageshwaran; Curtis Osborne; Andrew J Lees; Anette Schrag Journal: J Neurol Neurosurg Psychiatry Date: 2013-07-04 Impact factor: 10.154
Authors: Catarina Godinho; Josefa Domingos; Guilherme Cunha; Ana T Santos; Ricardo M Fernandes; Daisy Abreu; Nilza Gonçalves; Helen Matthews; Tom Isaacs; Joy Duffen; Ahmed Al-Jawad; Frank Larsen; Artur Serrano; Peter Weber; Andrea Thoms; Stefan Sollinger; Holm Graessner; Walter Maetzler; Joaquim J Ferreira Journal: J Neuroeng Rehabil Date: 2016-03-12 Impact factor: 4.262
Authors: Soma Makai-Bölöni; Eva Thijssen; Emilie M J van Brummelen; Geert J Groeneveld; Robert J Doll Journal: PLoS One Date: 2021-12-07 Impact factor: 3.240